Skip to content
info@hlthcommunications.com
Instagram
Linkedin
X-twitter
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
Get In Touch
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
Get In Touch
Mentions in the Press
Highlighting Our Clients' Media Coverage
See how our clients are making headlines with impactful stories and expert insights featured in top-tier media outlets.
Why Having a Dog Is So Good for Your Mental Health (Scientifically Speaking)
Read Now
New Study Looks at How the Brain Changes During Pregnancy and It’s Incredible
Read Now
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
Read Now
Enveric inks $62M licensing deal for psilocin prodrug
Read Now
Stealth mode biotech startups: Everything you need to know
Read Now
Enveric Biosciences Presents Compelling Preclinical Data On Lead Compound EB-003 At 7th Neuropsychiatric Drug Summit
Read Now
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences’ Breakthrough Research
Read Now
The Future Of MDMA-Assisted Therapy After FDA Rejection — Where Do We Go Now?
Read Now
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
Read Now
Enveric Biosciences Announces Promising Preclinical Results for EB-003
Read Now
Previous
Next